Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2022-10-20 Declaration of Voting R…
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding and voting rights for an instrument (Ordinary SE0000683484) held by Invesco Ltd. in CellaVision AB. It explicitly shows the 'Before the transaction' and 'After the transaction' share quantities and the resulting percentage of voting rights (5.02019%). This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is a formal report of a transaction/holding change, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2022-10-20 English
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a 'delårsrapport' (interim report) for CellaVision covering the period Q2 and January-June 2022. It contains detailed financial statements, including income statements, cash flow analysis, and regional performance breakdowns, as well as management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2022
2022-07-20 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'CellaVision Interim Report Q2 January-June 2022'. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed management commentary on regional performance, innovation, and strategic direction for the six-month period. It is a substantive financial report rather than a brief announcement or certification, fitting the definition of an Interim/Quarterly Report. Q2 2022
2022-07-20 English
Bulletin from the Annual General Meeting of CellaVision AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Bulletin from the Annual General Meeting of CellaVision AB (publ)" and details resolutions passed at the AGM, including profit allocation (dividend), board elections, auditor appointment, and approval of the remuneration report. This content directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (3122 chars) is substantial enough to be the report itself, not just an announcement of a report.
2022-05-11 English
Kommuniké från årsstämma i CellaVision AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kommuniké från årsstämma i CellaVision AB (publ)" which translates to 'Communiqué from the Annual General Meeting (AGM) in CellaVision AB (publ)'. The text details decisions made at the AGM on May 11, 2022, including the approval of financial statements, dividend distribution (2 SEK per share), election/re-election of board members and auditor (KPMG AB), and approval of the remuneration report. These contents are characteristic of the official minutes or summary released immediately following an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length is relatively short (2884 chars), but it contains the substantive decisions rather than just announcing that a report is available, distinguishing it from an RPA.
2022-05-11 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a 'delårsrapport' (interim report) for CellaVision covering the period January-March 2022. It contains comprehensive financial statements, management commentary, regional performance analysis, and a board declaration. It is a full quarterly report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-10 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.